Loading clinical trials...
Loading clinical trials...
Prospective, Randomized Phase 2 Clinical Trial of Mesenchymal Stem Cells(MSCs) for the Treatment of Coronavirus Disease 2019(COVID-19)
Conditions
Interventions
Mesenchymal stem cells
Placebo
Locations
1
Pakistan
NIBMT
Rawalpindi, Punjab Province, Pakistan
Start Date
May 1, 2020
Primary Completion Date
August 30, 2020
Completion Date
September 30, 2020
Last Updated
June 30, 2020
NCT07221162
NCT06082518
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
Dr. Zaineb Akram
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions